CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine
CD Bioparticles is pleased to announce a suite of mRNA-LNP Vaccine Laboratory Process Development Assays. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce a suite of comprehensive mRNA-LNP Vaccine Laboratory Process Development Assays. This latest addition to CD Bioparticles’ extensive service portfolio...
0 Comments 0 Shares 119 Views
Sponsored